Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18956
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBerkovic, Samuel F-
dc.date.accessioned2018-09-12T23:55:42Z-
dc.date.available2018-09-12T23:55:42Z-
dc.date.issued2017-
dc.identifier.citationThe New England journal of medicine 2017; 376(21): 2075-2076-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/18956-
dc.language.isoeng-
dc.titleCannabinoids for Epilepsy - Real Data, at Last.-
dc.typeEditorial-
dc.typeComment-
dc.identifier.journaltitleThe New England journal of medicine-
dc.identifier.affiliationEpilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia-
dc.identifier.doi10.1056/NEJMe1702205-
dc.identifier.orcid0000-0003-4580-841X-
dc.identifier.pubmedid28538129-
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.